Over the past years, the introduction of biological assay systems, random p
eptide sequencing and orphan receptor screening has led to the isolation an
d identification of new regulatory peptides with potential clinical impact.
We have developed a method for separating peptides into about 300 fraction
s from large amounts of porcine brain tissue. The preparation of this pepti
de bank consists of three steps including ultrafiltration followed by catio
n-exchange separation and reversed-phase chromatography. These fractions re
present the peptide bank with desalted and lyophilized peptides from brain
tissue. Molecular masses of the peptides in the fractions are determined by
matrix-assisted laser desorption ionization MS and a mass data bank is sub
sequently generated. For systematic analysis of the peptides, a subsequent
two-step purification procedure is followed by Edman sequencing resulting i
n the identification of different peptides. A survival assay with a neurona
l cell line revealing the stimulatory and inhibitory activities is applied
as a model to test the 300 fractions. This primary screen indicates that th
e biological activities of the extracted peptides are easily characterized
and, moreover, can be related to the biochemical entities. We conclude that
the established peptide bank is an efficient and useful tool for the isola
tion of regulatory brain peptides applying different purification strategie
s. (C) 1999 Elsevier Science B.V. All rights reserved.